- $42.41m
- $42.17m
- 12
- 38
- 27
- 15
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 0.211 | 0.73 | 3.67 | 4.76 | 4.91 |
Operating Profit | -0.211 | -0.73 | -3.67 | -4.76 | -4.91 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.248 | -0.752 | -3.72 | -4.73 | -4.91 |
Net Income After Taxes | -0.248 | -0.752 | -3.72 | -4.73 | -4.91 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.248 | -0.752 | -3.72 | -4.73 | -4.91 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.248 | -0.752 | -3.72 | -4.73 | -4.91 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.009 | -0.025 | -0.059 | -0.07 | -0.069 |